Results 301 to 310 of about 1,591,431 (356)

mRNA vaccines — a new era in vaccinology

open access: yesNature Reviews Drug Discovery, 2018
Norbert Pardi   +2 more
exaly   +2 more sources

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

open access: yesNature Reviews Drug Discovery, 2021
Over the past several decades, messenger RNA (mRNA) vaccines have progressed from a scepticism-inducing idea to clinical reality. In 2020, the COVID-19 pandemic catalysed the most rapid vaccine development in history, with mRNA vaccines at the forefront ...
Namit Chaudhary   +2 more
exaly   +2 more sources

Therapeutic cancer vaccines

Nature Reviews Cancer, 2021
Sjoerd H Van Der Burg   +2 more
exaly   +2 more sources

The role of vaccines in combatting antimicrobial resistance

open access: yesNature Reviews Microbiology, 2021
The use of antibiotics has enabled the successful treatment of bacterial infections, saving the lives and improving the health of many patients worldwide.
Francesca Micoli, Rino Rappuoli
exaly   +2 more sources

Developing Covid-19 Vaccines at Pandemic Speed.

New England Journal of Medicine, 2020
Developing Covid-19 Vaccines at Pandemic Speed An ideal vaccine platform would support development from viral sequencing to clinical trials in less than 16 weeks, demonstrate elicitation of consist...
N. Lurie   +3 more
semanticscholar   +1 more source

Vaccines, vaccination in Brucellosis

Annales de l'Institut Pasteur / Microbiologie, 1987
International ...
Plommet, Michel   +2 more
openaire   +3 more sources

COVID-19 vaccines

Reactions weekly, 2021
COVID-19 is a pandemic of unprecedented proportions in recent human history. Less than 18 months since the onset of the pandemic, there are close to two hundred million confirmed cases and four million deaths worldwide.
D. Ndwandwe, C. Wiysonge
semanticscholar   +1 more source

Vaccines and Vaccination

New England Journal of Medicine, 2001
More than 70 bacteria, viruses, parasites, and fungi are serious human pathogens.1 Vaccines are available against some of these agents and are being developed against almost all the other bacteria and viruses and about half of the parasites. Table 1 lists infections for which there are now licensed vaccines and those for which a candidate vaccine has ...
openaire   +2 more sources

Cytomegalovirus vaccines

Journal of Infectious Diseases, 1981
Congenital cytomegalovirus disease is an unsolved public health problem, unlikely to be solved by means other than immune prophylaxis. Development of a vaccine has been hampered by low awareness of the problem, which is caused by the often delayed detection of abnormalities after birth. Nevertheless, cytomegalovirus vaccine development is active.
openaire   +3 more sources

Home - About - Disclaimer - Privacy